Home / Denmark / Novozymes A/S

Novozymes A/S

Short position disclosed on March 31, 2026.

1.00% of the capital sold short

1 disclosing funds

222 disclosures on record

DK0060336014 ISIN code

Evolution of the disclosed total

0%0.25%0.5%0.75%1%

Oct 2025Jan 2026Apr 2026Jul 2026

Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.

The whole history, peaking at 1.00% on March 31, 2026. The shaded band is the year shown above.

November 1, 2012 today

Open positions

The funds disclosing a short position that is still open.
Fund	Twelve months	% of capital	Over the year	Since
AQR Capital Management, LLC		1.00%	new	March 31, 2026

On the other side: the funds that hold Novozymes A/S Titelia

History of disclosures

222 disclosures on record for this share.
Date	Fund	% of capital	End of publication
June 7, 2019	Marshall Wace LLP	0.65%	June 7, 2019
May 29, 2019	Marshall Wace LLP	0.70%	May 29, 2019
May 15, 2019	Marshall Wace LLP	0.60%	May 15, 2019
May 8, 2019	Marshall Wace LLP	0.50%	May 8, 2019
April 11, 2019	Citadel Europe LLP	0.46%	April 11, 2019
March 7, 2019	Citadel Europe LLP	0.52%	March 7, 2019
March 4, 2019	Citadel Europe LLP	0.49%	March 4, 2019
February 20, 2019	Citadel Europe LLP	0.50%	February 20, 2019
October 10, 2018	Marshall Wace LLP	0.46%	October 10, 2018
October 4, 2018	Marshall Wace LLP	0.59%	October 4, 2018
September 14, 2018	Marshall Wace LLP	0.68%	September 14, 2018
August 29, 2018	Marshall Wace LLP	0.70%	August 29, 2018
July 19, 2018	Marshall Wace LLP	0.68%	July 19, 2018
July 12, 2018	Marshall Wace LLP	0.70%	July 12, 2018
July 2, 2018	Marshall Wace LLP	0.62%	July 2, 2018
June 19, 2018	Marshall Wace LLP	0.52%	June 19, 2018
May 17, 2018	Marshall Wace LLP	0.49%	May 17, 2018
May 9, 2018	Marshall Wace LLP	0.57%	May 9, 2018
May 8, 2018	Marshall Wace LLP	0.60%	May 8, 2018
May 4, 2018	Marshall Wace LLP	0.59%	May 4, 2018
April 30, 2018	Marshall Wace LLP	0.68%	April 30, 2018
April 13, 2018	Marshall Wace LLP	0.78%	April 13, 2018
April 6, 2018	Marshall Wace LLP	0.87%	April 6, 2018
April 3, 2018	Marshall Wace LLP	0.90%	April 3, 2018
March 19, 2018	Marshall Wace LLP	0.81%	March 19, 2018
March 6, 2018	Marshall Wace LLP	0.70%	March 6, 2018
March 6, 2018	AQR Capital Management, LLC	0.49%	March 6, 2018
February 13, 2018	AQR Capital Management, LLC	0.58%	February 13, 2018
January 30, 2018	Marshall Wace LLP	0.60%	January 30, 2018
January 24, 2018	AQR Capital Management, LLC	0.69%	January 24, 2018
January 24, 2018	Marshall Wace LLP	0.59%	January 24, 2018
January 10, 2018	AQR Capital Management, LLC	0.79%	January 10, 2018
January 8, 2018	Marshall Wace LLP	0.69%	January 8, 2018
December 18, 2017	AQR Capital Management, LLC	0.89%	December 18, 2017
November 21, 2017	AQR Capital Management, LLC	0.99%	November 21, 2017
October 19, 2017	AQR Capital Management, LLC	1.09%	October 19, 2017
October 9, 2017	Marshall Wace LLP	0.79%	October 9, 2017
September 15, 2017	Marshall Wace LLP	0.89%	September 15, 2017
September 14, 2017	AQR Capital Management, LLC	1.19%	September 14, 2017
August 23, 2017	Marshall Wace LLP	0.90%	August 23, 2017
August 14, 2017	Marshall Wace LLP	0.80%	August 14, 2017
July 26, 2017	Marshall Wace LLP	0.70%	July 26, 2017
June 15, 2017	Marshall Wace LLP	0.60%	June 15, 2017
May 23, 2017	Marshall Wace LLP	0.59%	May 23, 2017
May 9, 2017	Marshall Wace LLP	0.68%	May 9, 2017
May 8, 2017	AQR Capital Management, LLC	1.20%	May 8, 2017
April 26, 2017	Marshall Wace LLP	0.71%	April 26, 2017
April 10, 2017	Marshall Wace LLP	0.60%	April 10, 2017
April 4, 2017	AQR Capital Management, LLC	1.10%	April 4, 2017
March 8, 2017	Marshall Wace LLP	0.58%	March 8, 2017

Other companies sold short in Denmark

Zealand Pharma A/S 6.75% of the capital sold short
GN Store Nord A/S 4.81% of the capital sold short
Ambu A/S 4.00% of the capital sold short
Pandora A/S 2.25% of the capital sold short
Carlsberg A/S 1.90% of the capital sold short
Demant A/S 1.89% of the capital sold short
Netcompany Group A/S 1.58% of the capital sold short
Aquaporin A/S 1.51% of the capital sold short
Matas A/S 1.28% of the capital sold short
Noble Corporation Plc 1.17% of the capital sold short
ChemoMetec A/S 0.92% of the capital sold short
Coloplast A/S 0.79% of the capital sold short

Download as CSV

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Novozymes A/S, source Finanstilsynet, data as at March 31, 2026, https://www.quivad.com/action/novozymes-a-s?page=4